Form4insider filings, from the source

Insider · CIK 0001184334

Robert E Conway

Files at: ALPN, ORKA. On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $285k · 7sales $0 · 0net $285k
$10k$10k$100k$100k$1M$1MbuyssalesDec 2015Mar 2016Jun 2016Sep 2016Jan 2017Apr 2017Jul 2017

Reported trades — common stock

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Jul 14, 2017 PForm 4 →Jul 17, 4:08 pm EDTARCA biopharma, Inc.ABIO10,000$2.49$24,90035,000+40.0% plan?
May 9, 2017 PForm 4 →May 10, 2:00 pm EDTNivalis Therapeutics, Inc.NVLS5,000$2.34$11,70045,000+12.5% plan?
May 8, 2017 PForm 4 →May 11, 12:17 pm EDTNivalis Therapeutics, Inc.NVLS15,000$2.28$34,20060,000+33.3% plan? late
May 5, 2017 PForm 4 →May 9, 2:01 pm EDTNivalis Therapeutics, Inc.NVLS20,000$2.30$46,00040,000+100% plan?
May 4, 2017 PForm 4 →May 8, 2:00 pm EDTNivalis Therapeutics, Inc.NVLS10,000$2.26$22,60020,000+100% plan?
Mar 24, 2017 PForm 4 →Mar 27, 4:06 pm EDTARCA biopharma, Inc.ABIO25,000$2.59$64,75025,000— plan?
Dec 9, 2015 PForm 4 →Dec 11, 9:01 am ESTNivalis Therapeutics, Inc.NVLS10,000$8.10$81,00010,000— plan?

Reported trades — derivatives (options, RSUs, warrants)

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Jan 2, 2019 AForm 4 →Jan 4, 4:02 pm ESTALPINE IMMUNE SCIENCES, INC.ALPN7,650——7,650—
Mar 1, 2018 AForm 4 →Mar 5, 5:35 pm ESTARCA biopharma, Inc.ABIO8,000——8,000—
Jan 2, 2018 AForm 4 →Jan 4, 5:18 pm ESTALPINE IMMUNE SCIENCES, INC.ALPN7,650——7,650—
Feb 16, 2017 AForm 4 →Feb 21, 4:49 pm ESTARCA biopharma, Inc.ABIO8,000——8,000—
Sep 12, 2016 AForm 4 →Sep 14, 4:16 pm EDTNivalis Therapeutics, Inc.NVLS12,300——12,300—
Feb 11, 2016 AForm 4 →Feb 16, 4:45 pm ESTARCA biopharma, Inc.ABIO8,000——8,000—
Sep 11, 2015 AForm 4 →Sep 15, 4:30 pm EDTNivalis Therapeutics, Inc.NVLS7,650——7,650—
Jul 16, 2015 AForm 4 →Jul 20, 3:47 pm EDTNivalis Therapeutics, Inc.NVLS11,475——11,475—
Feb 12, 2015 AForm 4 →Feb 17, 6:18 pm ESTARCA biopharma, Inc.ABIO8,000——8,000—